The IRB has the responsibility of ensuring federal, state, and university guidelines are followed in research involving human participants. It protects not only the rights of the people involved, but also the ethicality of the research.
The Brandeis University IRB is dedicated to ensuring that all research conducted under the auspices of the university follows the three basic ethical principles outlined in "The Belmont Report":
RESPECTRecognizing the personal dignity and autonomy of individuals and the protection of persons with diminished autonomy.
This means that research participants voluntarily consent to participate in research, that informed consent is obtained, that their privacy and confidentiality are protected, and that they have the right to withdraw from research participation without penalty.
BENEFICENCEProtecting persons from harm by maximizing anticipated benefits and minimizing possible risks of harm.
This means that the risks of research are justified by the potential benefits to the individual or society, the study is designed so that risks to participants are minimized, and conflicts of interest are managed adequately.
JUSTICEDistributing the risks and potential benefits of research equally among those who may benefit from the research.
This means that vulnerable populations are not targeted for convenience and people who are likely to benefit from research participation are not systematically excluded.
Our IRB follows the Department of Health and Human Services (HHS) regulations at 45 CFR Part 46, which constitute the Federal Policy, also known as the Common Rule, for the protection of human subjects in research.
These regulations are enforced by the HHS through the Office for Human Research Protections (OHRP).
Every institution that receives funding from HHS must have an Assurance of protection for human subjects. Brandeis University operates under Federalwide Assurance #FWA00004408, and our IRB is registered under #IRB00000562.